View Financial HealthBeijing Labtech Instruments 배당 및 자사주 매입배당 기준 점검 2/6Beijing Labtech Instruments 은(는) 현재 수익률이 2.05% 인 배당금 지급 회사입니다.핵심 정보2.0%배당 수익률0.5%자사주 매입 수익률총 주주 수익률2.6%미래 배당 수익률2.0%배당 성장률13.9%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향109%최근 배당 및 자사주 매입 업데이트공지 • Mar 01Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces an Equity Buyback for CNY 30 million worth of its shares.Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 35 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid till 6 months.모든 업데이트 보기Recent updatesReported Earnings • Apr 28Full year 2025 earnings released: EPS: CN¥0.60 (vs CN¥0.59 in FY 2024)Full year 2025 results: EPS: CN¥0.60 (up from CN¥0.59 in FY 2024). Revenue: CN¥401.1m (down 5.4% from FY 2024). Net income: CN¥40.4m (up 3.2% from FY 2024). Profit margin: 10% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 8% per year.공지 • Apr 28Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China공지 • Mar 30Beijing Labtech Instruments Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥31.55, the stock trades at a trailing P/E ratio of 53.5x. Average trailing P/E is 58x in the Electronic industry in China. Total loss to shareholders of 27% over the past three years.Reported Earnings • Mar 01Full year 2025 earnings released: EPS: CN¥0.59 (vs CN¥0.59 in FY 2024)Full year 2025 results: EPS: CN¥0.59 (in line with FY 2024). Revenue: CN¥402.2m (down 5.1% from FY 2024). Net income: CN¥39.4m (flat on FY 2024). Profit margin: 9.8% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 3% per year.New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risk Dividend is not well covered by earnings (109% payout ratio).공지 • Dec 26Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026Reported Earnings • Oct 28Third quarter 2025 earnings released: EPS: CN¥0.17 (vs CN¥0.18 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.17. Revenue: CN¥92.9m (down 4.2% from 3Q 2024). Net income: CN¥11.5m (up 1.8% from 3Q 2024). Profit margin: 12% (in line with 3Q 2024). Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Electronic industry in China.공지 • Sep 30Beijing Labtech Instruments Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025공지 • Jun 30Beijing Labtech Instruments Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.17 in 1Q 2024). Revenue: CN¥99.1m (down 6.1% from 1Q 2024). Net income: CN¥12.8m (up 10% from 1Q 2024). Profit margin: 13% (up from 11% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.공지 • Apr 25Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025, at 13:30 China Standard Time. Location: The Company's Meeting Room, Beijing ChinaValuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥35.32, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 25x in the Electronic industry in China. Total returns to shareholders of 3.5% over the past three years.New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 171% Cash payout ratio: 91% Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).공지 • Mar 28Beijing Labtech Instruments Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025Reported Earnings • Feb 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: CN¥0.60 (up from CN¥0.41 in FY 2023). Revenue: CN¥424.4m (up 2.0% from FY 2023). Net income: CN¥39.7m (up 44% from FY 2023). Profit margin: 9.4% (up from 6.6% in FY 2023). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 9.9%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥31.63, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years.공지 • Dec 27Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥35.98, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 45% over the past three years.분석 기사 • Oct 09Why Investors Shouldn't Be Surprised By Beijing Labtech Instruments Co., Ltd.'s (SHSE:688056) 41% Share Price SurgeThe Beijing Labtech Instruments Co., Ltd. ( SHSE:688056 ) share price has done very well over the last month, posting...Valuation Update With 7 Day Price Move • Oct 01Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥25.93, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.92 per share.공지 • Sep 30Beijing Labtech Instruments Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.공지 • Jun 28Beijing Labtech Instruments Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥23.83, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 22x in the Electronic industry in China. Total loss to shareholders of 61% over the past three years.분석 기사 • May 02Beijing Labtech Instruments' (SHSE:688056) Soft Earnings Are Actually Better Than They AppearThe market was pleased with the recent earnings report from Beijing Labtech Instruments Co., Ltd. ( SHSE:688056...Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.17 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥105.5m (up 9.2% from 1Q 2023). Net income: CN¥11.6m (down 10.0% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.공지 • Apr 27Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing ChinaValuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥19.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 21x in the Electronic industry in China. Total loss to shareholders of 44% over the past three years.New Risk • Apr 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (6.8% net profit margin).공지 • Mar 29Beijing Labtech Instruments Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024분석 기사 • Mar 08Beijing Labtech Instruments Co., Ltd. (SHSE:688056) Looks Just Right With A 29% Price JumpThose holding Beijing Labtech Instruments Co., Ltd. ( SHSE:688056 ) shares would be relieved that the share price has...공지 • Mar 01Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces an Equity Buyback for CNY 30 million worth of its shares.Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 35 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid till 6 months.Reported Earnings • Feb 26Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.42 (down from CN¥0.67 in FY 2022). Revenue: CN¥415.5m (up 17% from FY 2022). Net income: CN¥28.1m (down 37% from FY 2022). Profit margin: 6.8% (down from 13% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 49%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.New Risk • Feb 25New major risk - Revenue and earnings growthEarnings have declined by 6.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Profit margins are more than 30% lower than last year (9.1% net profit margin).New Risk • Feb 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Profit margins are more than 30% lower than last year (9.1% net profit margin).Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥24.17, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 17x in the Electronic industry in China. Total loss to shareholders of 18% over the past three years.Board Change • Jan 23Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jianming Zheng was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공지 • Dec 30Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.18 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.058 (down from CN¥0.18 in 3Q 2022). Revenue: CN¥103.7m (up 11% from 3Q 2022). Net income: CN¥3.83m (down 69% from 3Q 2022). Profit margin: 3.7% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 29Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (in line with 2Q 2022). Revenue: CN¥99.7m (up 28% from 2Q 2022). Net income: CN¥9.96m (down 2.2% from 2Q 2022). Profit margin: 10.0% (down from 13% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Electronic industry in China.공지 • Jun 28Beijing Labtech Instruments Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2023 results on Aug 29, 2023Reported Earnings • Apr 26First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2022). Revenue: CN¥96.6m (up 25% from 1Q 2022). Net income: CN¥12.9m (up 8.0% from 1Q 2022). Profit margin: 13% (down from 15% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiaoyan Kong was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.29 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.29 in 3Q 2021). Revenue: CN¥93.5m (up 7.9% from 3Q 2021). Net income: CN¥12.4m (down 35% from 3Q 2021). Profit margin: 13% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.80, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 19x in the Electronic industry in China. Total returns to shareholders of 4.4% over the past year.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.29 in 2Q 2021). Revenue: CN¥78.0m (down 24% from 2Q 2021). Net income: CN¥10.2m (down 48% from 2Q 2021). Profit margin: 13% (down from 19% in 2Q 2021). The decrease in margin was driven by lower revenue.Valuation Update With 7 Day Price Move • Aug 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥41.00, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 16% over the past year.Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥37.06, the stock trades at a trailing P/E ratio of 37.2x. Average forward P/E is 20x in the Electronic industry in China. Total loss to shareholders of 50% over the past year.Reported Earnings • Apr 27First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.22 in 1Q 2021). Revenue: CN¥77.5m (down 2.6% from 1Q 2021). Net income: CN¥11.9m (down 18% from 1Q 2021). Profit margin: 15% (down from 18% in 1Q 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 63%, compared to a 24% growth forecast for the industry in China.Reported Earnings • Feb 28Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥1.05 (down from CN¥1.17 in FY 2020). Revenue: CN¥369.4m (up 6.0% from FY 2020). Net income: CN¥70.2m (up 7.6% from FY 2020). Profit margin: 19% (in line with FY 2020). Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 52%, compared to a 26% growth forecast for the industry in China.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥74.44, the stock trades at a forward P/E ratio of 55x. Average forward P/E is 31x in the Electronic industry in China. Total returns to shareholders of 109% over the past year.Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥61.30, the stock trades at a trailing P/E ratio of 49.9x. Average forward P/E is 29x in the Electronic industry in China. Total returns to shareholders of 43% over the past year.Reported Earnings • Oct 27Third quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.30 in 3Q 2020)The company reported a solid third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥86.6m (flat on 3Q 2020). Net income: CN¥19.2m (up 15% from 3Q 2020). Profit margin: 22% (up from 19% in 3Q 2020).Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.29 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥102.6m (up 9.2% from 2Q 2020). Net income: CN¥19.6m (down 1.7% from 2Q 2020). Profit margin: 19% (down from 21% in 2Q 2020). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥62.66, the stock trades at a trailing P/E ratio of 50.3x. Average forward P/E is 30x in the Electronic industry in China.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥54.36, the stock trades at a trailing P/E ratio of 43.6x. Average forward P/E is 31x in the Electronic industry in China.Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 30% share price gain to CN¥73.41, the stock trades at a trailing P/E ratio of 58.9x. Average forward P/E is 25x in the Electronic industry in China.Valuation Update With 7 Day Price Move • May 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥47.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 33x in the Electronic industry in China.Reported Earnings • Apr 29Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥1.23 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥348.6m (down 8.4% from FY 2019). Net income: CN¥65.2m (up 6.3% from FY 2019). Profit margin: 19% (up from 16% in FY 2019). The increase in margin was driven by lower expenses.Is New 90 Day High Low • Mar 08New 90-day high: CN¥41.17The company is up 6.0% from its price of CN¥38.79 on 08 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 3.0% over the same period.Valuation Update With 7 Day Price Move • Mar 05Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥37.38, the stock is trading at a trailing P/E ratio of 30.6x, up from the previous P/E ratio of 25.5x. This compares to an average P/E of 40x in the Electronic industry in China.Is New 90 Day High Low • Jan 07New 90-day low: CN¥28.97The company is down 20% from its price of CN¥36.35 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 7.0% over the same period.Is New 90 Day High Low • Dec 16New 90-day low: CN¥35.08The company is down 13% from its price of CN¥40.40 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period.Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 20% share price gain to CN¥44.99, the stock is trading at a trailing P/E ratio of 39.7x, up from the previous P/E ratio of 33.2x. This compares to an average P/E of 44x in the Medical Equipment industry in China.공지 • Oct 20Beijing Labtech Instruments Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 688056 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: 688056 의 배당금 지급이 증가했지만 회사는 5 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장Beijing Labtech Instruments 배당 수익률 vs 시장688056의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (688056)2.0%시장 하위 25% (CN)0.4%시장 상위 25% (CN)1.8%업계 평균 (Electronic)1.0%분석가 예측 (688056) (최대 3년)2.0%주목할만한 배당금: 688056 의 배당금( 2.05% )은 CN 시장에서 배당금 지급자의 하위 25%( 0.35% )보다 높습니다.고배당: 688056 의 배당금( 2.05% )은 CN 시장( 1.81% )주주 대상 이익 배당수익 보장: 지급 비율 ( 109% )이 높기 때문에 688056 의 배당금 지급은 수익으로 잘 충당되지 않습니다.주주 현금 배당현금 흐름 범위: 현금 지급 비율 ( 284.1% )이 높기 때문에 688056 의 배당금 지급은 현금 흐름으로 잘 충당되지 않습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YCN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/12 01:09종가2026/05/12 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Beijing Labtech Instruments Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Zhongshu YinEverbright Securities Co. Ltd.
공지 • Mar 01Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces an Equity Buyback for CNY 30 million worth of its shares.Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 35 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid till 6 months.
Reported Earnings • Apr 28Full year 2025 earnings released: EPS: CN¥0.60 (vs CN¥0.59 in FY 2024)Full year 2025 results: EPS: CN¥0.60 (up from CN¥0.59 in FY 2024). Revenue: CN¥401.1m (down 5.4% from FY 2024). Net income: CN¥40.4m (up 3.2% from FY 2024). Profit margin: 10% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 8% per year.
공지 • Apr 28Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China
공지 • Mar 30Beijing Labtech Instruments Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥31.55, the stock trades at a trailing P/E ratio of 53.5x. Average trailing P/E is 58x in the Electronic industry in China. Total loss to shareholders of 27% over the past three years.
Reported Earnings • Mar 01Full year 2025 earnings released: EPS: CN¥0.59 (vs CN¥0.59 in FY 2024)Full year 2025 results: EPS: CN¥0.59 (in line with FY 2024). Revenue: CN¥402.2m (down 5.1% from FY 2024). Net income: CN¥39.4m (flat on FY 2024). Profit margin: 9.8% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 3% per year.
New Risk • Feb 14New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risk Dividend is not well covered by earnings (109% payout ratio).
공지 • Dec 26Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026
Reported Earnings • Oct 28Third quarter 2025 earnings released: EPS: CN¥0.17 (vs CN¥0.18 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.17. Revenue: CN¥92.9m (down 4.2% from 3Q 2024). Net income: CN¥11.5m (up 1.8% from 3Q 2024). Profit margin: 12% (in line with 3Q 2024). Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Electronic industry in China.
공지 • Sep 30Beijing Labtech Instruments Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025
공지 • Jun 30Beijing Labtech Instruments Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025
Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.17 in 1Q 2024). Revenue: CN¥99.1m (down 6.1% from 1Q 2024). Net income: CN¥12.8m (up 10% from 1Q 2024). Profit margin: 13% (up from 11% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
공지 • Apr 25Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025, at 13:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥35.32, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 25x in the Electronic industry in China. Total returns to shareholders of 3.5% over the past three years.
New Risk • Apr 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 171% Cash payout ratio: 91% Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change).
공지 • Mar 28Beijing Labtech Instruments Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025
Reported Earnings • Feb 26Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: CN¥0.60 (up from CN¥0.41 in FY 2023). Revenue: CN¥424.4m (up 2.0% from FY 2023). Net income: CN¥39.7m (up 44% from FY 2023). Profit margin: 9.4% (up from 6.6% in FY 2023). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 9.9%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥31.63, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years.
공지 • Dec 27Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025
Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥35.98, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 45% over the past three years.
분석 기사 • Oct 09Why Investors Shouldn't Be Surprised By Beijing Labtech Instruments Co., Ltd.'s (SHSE:688056) 41% Share Price SurgeThe Beijing Labtech Instruments Co., Ltd. ( SHSE:688056 ) share price has done very well over the last month, posting...
Valuation Update With 7 Day Price Move • Oct 01Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥25.93, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.92 per share.
공지 • Sep 30Beijing Labtech Instruments Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024
New Risk • Sep 17New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
공지 • Jun 28Beijing Labtech Instruments Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024
Valuation Update With 7 Day Price Move • Jun 13Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥23.83, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 22x in the Electronic industry in China. Total loss to shareholders of 61% over the past three years.
분석 기사 • May 02Beijing Labtech Instruments' (SHSE:688056) Soft Earnings Are Actually Better Than They AppearThe market was pleased with the recent earnings report from Beijing Labtech Instruments Co., Ltd. ( SHSE:688056...
Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.17 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥105.5m (up 9.2% from 1Q 2023). Net income: CN¥11.6m (down 10.0% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
공지 • Apr 27Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥19.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 21x in the Electronic industry in China. Total loss to shareholders of 44% over the past three years.
New Risk • Apr 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (6.8% net profit margin).
공지 • Mar 29Beijing Labtech Instruments Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
분석 기사 • Mar 08Beijing Labtech Instruments Co., Ltd. (SHSE:688056) Looks Just Right With A 29% Price JumpThose holding Beijing Labtech Instruments Co., Ltd. ( SHSE:688056 ) shares would be relieved that the share price has...
공지 • Mar 01Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces an Equity Buyback for CNY 30 million worth of its shares.Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 35 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid till 6 months.
Reported Earnings • Feb 26Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.42 (down from CN¥0.67 in FY 2022). Revenue: CN¥415.5m (up 17% from FY 2022). Net income: CN¥28.1m (down 37% from FY 2022). Profit margin: 6.8% (down from 13% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 49%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
New Risk • Feb 25New major risk - Revenue and earnings growthEarnings have declined by 6.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Profit margins are more than 30% lower than last year (9.1% net profit margin).
New Risk • Feb 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Profit margins are more than 30% lower than last year (9.1% net profit margin).
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥24.17, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 17x in the Electronic industry in China. Total loss to shareholders of 18% over the past three years.
Board Change • Jan 23Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jianming Zheng was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공지 • Dec 30Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.18 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.058 (down from CN¥0.18 in 3Q 2022). Revenue: CN¥103.7m (up 11% from 3Q 2022). Net income: CN¥3.83m (down 69% from 3Q 2022). Profit margin: 3.7% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 29Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.15 (in line with 2Q 2022). Revenue: CN¥99.7m (up 28% from 2Q 2022). Net income: CN¥9.96m (down 2.2% from 2Q 2022). Profit margin: 10.0% (down from 13% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Electronic industry in China.
공지 • Jun 28Beijing Labtech Instruments Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2023 results on Aug 29, 2023
Reported Earnings • Apr 26First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2022). Revenue: CN¥96.6m (up 25% from 1Q 2022). Net income: CN¥12.9m (up 8.0% from 1Q 2022). Profit margin: 13% (down from 15% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiaoyan Kong was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.29 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.29 in 3Q 2021). Revenue: CN¥93.5m (up 7.9% from 3Q 2021). Net income: CN¥12.4m (down 35% from 3Q 2021). Profit margin: 13% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥42.80, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 19x in the Electronic industry in China. Total returns to shareholders of 4.4% over the past year.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.29 in 2Q 2021). Revenue: CN¥78.0m (down 24% from 2Q 2021). Net income: CN¥10.2m (down 48% from 2Q 2021). Profit margin: 13% (down from 19% in 2Q 2021). The decrease in margin was driven by lower revenue.
Valuation Update With 7 Day Price Move • Aug 10Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥41.00, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 16% over the past year.
Valuation Update With 7 Day Price Move • Jun 01Investor sentiment improved over the past weekAfter last week's 22% share price gain to CN¥37.06, the stock trades at a trailing P/E ratio of 37.2x. Average forward P/E is 20x in the Electronic industry in China. Total loss to shareholders of 50% over the past year.
Reported Earnings • Apr 27First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.22 in 1Q 2021). Revenue: CN¥77.5m (down 2.6% from 1Q 2021). Net income: CN¥11.9m (down 18% from 1Q 2021). Profit margin: 15% (down from 18% in 1Q 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 63%, compared to a 24% growth forecast for the industry in China.
Reported Earnings • Feb 28Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: CN¥1.05 (down from CN¥1.17 in FY 2020). Revenue: CN¥369.4m (up 6.0% from FY 2020). Net income: CN¥70.2m (up 7.6% from FY 2020). Profit margin: 19% (in line with FY 2020). Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 52%, compared to a 26% growth forecast for the industry in China.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥74.44, the stock trades at a forward P/E ratio of 55x. Average forward P/E is 31x in the Electronic industry in China. Total returns to shareholders of 109% over the past year.
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥61.30, the stock trades at a trailing P/E ratio of 49.9x. Average forward P/E is 29x in the Electronic industry in China. Total returns to shareholders of 43% over the past year.
Reported Earnings • Oct 27Third quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.30 in 3Q 2020)The company reported a solid third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥86.6m (flat on 3Q 2020). Net income: CN¥19.2m (up 15% from 3Q 2020). Profit margin: 22% (up from 19% in 3Q 2020).
Reported Earnings • Aug 26Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.29 in 2Q 2020)The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥102.6m (up 9.2% from 2Q 2020). Net income: CN¥19.6m (down 1.7% from 2Q 2020). Profit margin: 19% (down from 21% in 2Q 2020). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 23% share price gain to CN¥62.66, the stock trades at a trailing P/E ratio of 50.3x. Average forward P/E is 30x in the Electronic industry in China.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥54.36, the stock trades at a trailing P/E ratio of 43.6x. Average forward P/E is 31x in the Electronic industry in China.
Valuation Update With 7 Day Price Move • May 29Investor sentiment improved over the past weekAfter last week's 30% share price gain to CN¥73.41, the stock trades at a trailing P/E ratio of 58.9x. Average forward P/E is 25x in the Electronic industry in China.
Valuation Update With 7 Day Price Move • May 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to CN¥47.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 33x in the Electronic industry in China.
Reported Earnings • Apr 29Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥1.23 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥348.6m (down 8.4% from FY 2019). Net income: CN¥65.2m (up 6.3% from FY 2019). Profit margin: 19% (up from 16% in FY 2019). The increase in margin was driven by lower expenses.
Is New 90 Day High Low • Mar 08New 90-day high: CN¥41.17The company is up 6.0% from its price of CN¥38.79 on 08 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 3.0% over the same period.
Valuation Update With 7 Day Price Move • Mar 05Investor sentiment improved over the past weekAfter last week's 20% share price gain to CN¥37.38, the stock is trading at a trailing P/E ratio of 30.6x, up from the previous P/E ratio of 25.5x. This compares to an average P/E of 40x in the Electronic industry in China.
Is New 90 Day High Low • Jan 07New 90-day low: CN¥28.97The company is down 20% from its price of CN¥36.35 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 7.0% over the same period.
Is New 90 Day High Low • Dec 16New 90-day low: CN¥35.08The company is down 13% from its price of CN¥40.40 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 19Market bids up stock over the past weekAfter last week's 20% share price gain to CN¥44.99, the stock is trading at a trailing P/E ratio of 39.7x, up from the previous P/E ratio of 33.2x. This compares to an average P/E of 44x in the Medical Equipment industry in China.
공지 • Oct 20Beijing Labtech Instruments Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020